Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Should people with duplicate EPICs be allowed? Should foreigners be allowed on the voter list? What is the objection about?' ...

London: GSK plc has announced the extension of the US Food and Drug Administration (FDA) review period for the Biologics ...

Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by ...

The Baloch Liberation Army has claimed responsibility for a bomb blast in Quetta that killed Major Anwar Kakar, a senior ...

Fatima Baloch Today, the Pakistan Army is embroiled in a brutal insurgency in its key provinces-Balochistan and Khyber Pakhtunkhwa (KPK). This internal conflict will undoubtedly impact India’s ...

Gyanesh Kumar asks if poll body should allow names of dead, migrants, or duplicate voters; stresses clean rolls are vital for democracy ...

The FDA has accepted for Priority Review the BLA for tividenofusp alfa for the treatment of Hunter syndrome, also known as MPS II.

ISLAMABAD – Pakistan has once again reaffirmed its firm stance against terrorism, calling for the international community to ...

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...